Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - OTHER CURRENT ASSETS
Other Current Assets HALO - Halozyme Therapeutics, Inc.
39 M
LAST VALUE
-6.99%
2 YEAR CAGR
-10.21%
5 YEAR CAGR
6.74%
10 YEAR CAGR